Biora Therapeutics finishes restructuring, now privately held with funds to boost BioJet™ platform development.

After completing a restructuring process, Biora has transitioned into a privately owned company. The company has secured long-term funding that will be utilized to expedite the advancement of the BioJet™ platform. This move signals a significant milestone for Biora as they focus on enhancing their technology. The specific amount of financing and other details surrounding the transition were not disclosed publicly.